Kubtec Patent Promotes Strong Prognosis for the Future of Breast Conserving Surgery

MILFORD, CT (August 14, 2015) – Kubtec®, the leader in innovation for digital specimen radiography systems, announces the U.S. Patent & Trademark Office has issued Patent No. 14/503,130 for the technology incorporated into the  Mozart® System with TomoSpec® Technology. This patent recognizes that the Mozart System with TomoSpec Technology, the world’s first portable 3-D Digital Specimen Tomosynthesis Imaging System, is unique in its field.

The Mozart System with TomoSpec Technology allows surgeons to bring 3-D tomosynthesis imaging directly into the Operating Room for lumpectomy and partial mastectomy procedures.  It gives surgical teams the ability to make faster and more precise intraoperative determinations of the successful excision of tumor margins.  Prior to the Mozart System with TomoSpec Technology, surgeons were restricted to less effective modes of multiple 2-D imaging, or waiting while a specimen was transported from the Operating Room to another location for 3-D analysis.   

“Surgeons often do not have the time to wait for off-site 3-D image analysis.  A result of this is that around 25% of lumpectomy patients will require a second procedure1, as follow up analysis frequently indicates that the tumor has not been completely excised during surgery,” says Vikram Butani, President and Chief Executive Officer of Kubtec. “Our goal is to reduce that number by giving surgeons and radiologists the most advanced digital specimen radiography tools that enable them to precisely identify tumor margins during the operation itself.  This shortens procedure times and decreases the risk that a re-excision will be necessary.  That’s better for the patient and it reduces hospital costs, too.”

Chester Lowe, Ph.D.  Director of Research and Development at Kubtec, commented, “This patent confirms how unique and important the technologies integrated into the design of the Mozart Digital Specimen Tomosynthesis Imaging System really are.  We believe that the Mozart System with TomoSpec Technology will have a major impact on breast cancer procedures and drive positive outcomes for patients.”

During Breast Cancer Awareness Month, Kubtec will be exhibiting Mozart System with TomoSpec Technology at the European Union Society of Breast Imaging (EUOSBI) in London, UK October October 2 & 3, 2015. 

About Kubtec
Kubtec, a registered trademark of KUB Technologies, Inc., offers the most innovative tools in digital x-ray equipment for specimen radiography, low-dose imaging, scientific research, forensic analysis, non-destructive testing, irradiation and more.  Kubtec is ISO 9001 and ISO 13485 certified and complies with U.S., Canadian, and European requirements for radiation safety.  Systems and manufacturer-trained support are available worldwide.  http://kubtec.com. Kubtec, the Kubtec logo, MOZART and TomoSpec are registered trademarks and KUB is a trademark of KUB Technologies, Inc.